Zacks upgrades Tenet to hold — 3 insights

Zacks Equity Research raised its guidance on Dallas-based Tenet Healthcare to “hold,” the Ledger Gazette reports.

Advertisement

Here’s what you should know.

1. Zacks raised its guidance based on Tenet’s increased 2018 guidance. Although the company has an alarming amount of uncollectible accounts, contributing to mounting bad debt, Tenet has begun streamlining its core operations and adopted an enterprisewide, cost-reducing program.

2. The market’s consensus rating is “hold.” Three analysts assigned a “sell” rating, nine a “hold” rating and seven a “buy” rating.

3. Analysts assigned an average price target of $20.56 per share.

More articles on transactions/valuations: 
Nobilis looking for more large in-network acquisitions in 2018: 5 key quotes from CEO Harry Fleming
Congress questions Joint Commission accreditation process — 7 insights
Common deficiencies cited by AAAASF and how to fix them: Administration of drugs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.